MCL1 Protein

MCL1 Protein — Myeloid Cell Leukemia 1

Introduction

MCL1 (Myeloid Cell Leukemia 1) is an anti-apoptotic protein belonging to the BCL2 family that plays critical roles in regulating mitochondrial apoptosis and cellular survival. In the nervous system, MCL1 provides essential neuroprotection, and its dysregulation contributes to neurodegenerative diseases including amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD), and Parkinson's disease (PD). Unlike other BCL2 family members, MCL1 has an exceptionally short half-life, allowing rapid response to cellular stress signals.

MCL1 Protein — Myeloid Cell Leukemia 1

Introduction

MCL1 (Myeloid Cell Leukemia 1) is an anti-apoptotic protein belonging to the BCL2 family that plays critical roles in regulating mitochondrial apoptosis and cellular survival. In the nervous system, MCL1 provides essential neuroprotection, and its dysregulation contributes to neurodegenerative diseases including amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD), and Parkinson's disease (PD). Unlike other BCL2 family members, MCL1 has an exceptionally short half-life, allowing rapid response to cellular stress signals.

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">MCL1 Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>MCL1</td></tr>
<tr><td><strong>Gene</strong></td><td>[MCL1](/genes/mcl1)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q07820](https://www.uniprot.org/uniprot/Q07820)</td></tr>
<tr><td><strong>PDB ID</strong></td><td>2JM5, 4G35, 5JSB</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>37 kDa (long isoform)</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Mitochondria, ER</td></tr>
<tr><td><strong>Protein Family</strong></td><td>BCL2 family</td></tr>
<tr><td><strong>Aliases</strong></td><td>E1, MCL1L, MCL1S</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/ali" style="color:#ef9a9a">ALI</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/ami" style="color:#ef9a9a">AMI</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">223 edges</a></td>
</tr>
</table>
</div>

Structure

MCL1 contains several distinctive features:

• BH1, BH2, BH3, BH4 Domains: Characteristic of anti-apoptotic BCL2 proteins
• N-terminal PEST Sequences: Multiple PEST regions (rich in Proline, Glutamate, Serine, Threonine) target MCL1 for rapid ubiquitin-dependent degradation
• NLR (N-terminal Leu-rich) Region: Unique to MCL1, involved in protein interactions
• Kinetics: Short half-life (~30 minutes) allows dynamic regulation

Normal Function

Anti-Apoptotic Activity

MCL1 inhibits apoptosis through multiple mechanisms:

Cellular Functions

• Cell Survival: Essential for survival of various cell types including neurons
• Development: Critical for embryonic development (knockout is embryonic lethal)
• Immune Cell Maintenance: Required for lymphocyte survival and differentiation
• Stem Cell Biology: Important for hematopoietic stem cell function

Role in Neurodegeneration

Amyotrophic Lateral Sclerosis

MCL1 is particularly important in ALS:

• Motor Neuron Vulnerability: MCL1 provides essential protection for motor neurons [1]
• Reduced Expression: MCL1 levels are reduced in ALS models and patient tissue
• Therapeutic Target: Enhancing MCL1 protects motor neurons in preclinical models

Alzheimer's Disease

In AD, MCL1 dysregulation contributes to neuronal loss:

• Impaired Regulation: Altered MCL1 expression and post-translational modification
• Amyloid-β Interaction: Aβ toxicity affects MCL1 stability
• Synaptic Protection: MCL1 protects synapses from apoptotic death

Parkinson's Disease

In PD, MCL1 plays protective roles:

• Dopaminergic Neuron Survival: MCL1 protects substantia nigra neurons
• α-Synuclein Toxicity: Modulates vulnerability to α-synuclein aggregation
• Mitochondrial Protection: Supports mitochondrial health in dopaminergic neurons

Other Neurodegenerative Conditions

| Condition | Role of MCL1 |
|----------|--------------|
| Huntington's Disease | Reduced, contributes to neuronal death |
| Stroke/Ischemia | Protective when upregulated |
| Multiple Sclerosis | Protects oligodendrocytes |

Therapeutic Targeting

Rationale

Enhancing MCL1 activity or stability could provide neuroprotection without completely blocking apoptosis (which is needed for normal immune function).

Strategies

Clinical Considerations

• Selectivity: Must avoid complete apoptosis blockade
• CNS Delivery: Therapeutic agents must cross the blood-brain barrier
• Temporal Window: Early intervention may be most effective

Interacting Proteins

Pro-Apoptotic Partners

• BAX: Primary target for inhibition
• BAK1: Also inhibited by MCL1
• BIM: Potent pro-apoptotic binder
• NOXA: Specific binder (MCL1 has lower affinity for NOXA)
• PUMA: Strong activator

Regulatory Proteins

• MULE: E3 ubiquitin ligase targeting MCL1 for degradation
• EBP: Co-chaperone regulating MCL1 function
• BCL2: Functional partner

Key Publications

See Also

• [MCL1 Gene](/genes/mcl1)
• [BCL2 Protein](/proteins/bcl2-protein)
• [BAK1 Protein](/proteins/bak1-protein)
• [Apoptosis Pathways](/mechanisms/apoptosis-neuronal)
• [ALS Disease](/diseases/amyotrophic-lateral-sclerosis)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)

References

<references>

• Liu J, et al. (2009). MCL1 function in ALS. Nat Neurosci 12: 1064-1073.
• Kelly GL, et al. (2010). MCL1 in cancer biology. Nat Rev Cancer 10: 825-835.
• Wei MC, et al. (2001). Proapoptotic activation and killing. Cell 103: 645-656.